LUDOVINI, VIENNA
 Distribuzione geografica
Continente #
NA - Nord America 574
EU - Europa 421
AS - Asia 206
SA - Sud America 3
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.206
Nazione #
US - Stati Uniti d'America 572
IT - Italia 151
IE - Irlanda 120
SG - Singapore 87
CN - Cina 43
HK - Hong Kong 42
DE - Germania 29
SE - Svezia 25
VN - Vietnam 25
FI - Finlandia 21
FR - Francia 17
RU - Federazione Russa 16
GB - Regno Unito 9
RO - Romania 9
UA - Ucraina 7
AT - Austria 6
KR - Corea 6
CH - Svizzera 5
BR - Brasile 2
NL - Olanda 2
AM - Armenia 1
BE - Belgio 1
BG - Bulgaria 1
BO - Bolivia 1
CA - Canada 1
CZ - Repubblica Ceca 1
EU - Europa 1
GR - Grecia 1
MA - Marocco 1
MX - Messico 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 1.206
Città #
Chandler 168
Dublin 120
Perugia 79
Singapore 66
Boardman 47
Hong Kong 42
San Mateo 37
Santa Clara 32
Dong Ket 25
Altamura 22
Ann Arbor 21
Medford 21
Princeton 21
Lawrence 18
Munich 18
Andover 15
Helsinki 15
Redmond 14
Beijing 13
Bucharest 9
Dearborn 9
Saint Petersburg 6
San Paolo di Civitate 6
Wilmington 6
Seoul 5
Vienna 5
Arezzo 4
Norwalk 4
Nuremberg 4
Guangzhou 3
Los Angeles 3
Montalto delle Marche 3
Moscow 3
Redwood City 3
Rome 3
Asso 2
Dallas 2
Houston 2
London 2
New York 2
Paris 2
Ashburn 1
Atlanta 1
Baoding 1
Bologna 1
Brussels 1
Cambridge 1
Chicago 1
Florence 1
Frankfurt am Main 1
Granarolo dell'Emilia e Viadagola 1
Groningen 1
Henderson 1
Izmir 1
Jinan 1
Kiev 1
Lappeenranta 1
Lausanne 1
Marsciano 1
Milan 1
Ottawa 1
Padova 1
Reston 1
Seattle 1
Shijiazhuang 1
Sofia 1
Sucre 1
São Paulo 1
Tashkent 1
Tianjin 1
Uberlândia 1
Woodbridge 1
Yerevan 1
Zurich 1
Totale 915
Nome #
Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications 147
Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer 80
Prognostic implication of aquaporin 1 overexpression in resected lung adenocarcinoma 68
A machine learning approach applied to Reverse Phase Protein Microarray data for pathways activation mapping of KRAS wild type and mutated adenocarcinomas of the lung 61
Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy 60
Prognostic Role of Circulating miRNAs in Early-Stage Non-Small Cell Lung Cancer 60
Pathway Activation Mapping of Kras Wild Type and Mutated Adenocarcinomas of the Lung: New Implications For Patient Stratification For Map Kinase Pathway Inhibition 58
PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients 55
Large Cell Neuroendocrine Carcinoma Transformation and EGFR-T790M Mutation as Coexisting Mechanisms of Acquired Resistance to EGFR-TKIs in Lung Cancer 54
Modified gene expression of alveolar-capillar membrane, extracellular matrix and membrane proteins after induction chemotherapy for Non-Small Cell Lung Cancer 54
Liquid Biopsy in early Breast Cancer: A preliminary Report 54
Variations in gene expression of lung macromolecules after induction chemotherapy for lung cancer 52
Dynamic network topologies analysis in proteomics data of NSCLC cell lines using a new pipeline based on machine learning tools 50
Reverse phase protein array (RPPA) combined with computational analysis to unravel relevant prognostic factors in non- small cell lung cancer (NSCLC): a pilot study 47
Prognostic implications of epidermal growth factor receptor, KRAS and BRAF gene mutations in resected non-small cell lung cancer patients 45
Higher tlr7 gene expression predicts poor clinical outcome in advanced nsclc patients treated with immunotherapy 44
PD-L1 quantification across tumor types using the reverse phase protein microarray: Implications for precision medicine 37
Serum level changes of matrix metalloproteinases 2 and 9, vascular endothelial growth factor and epidermal growth factor receptor during platinum-based chemotherapy in advanced non-small cell lung cancer patients 35
Sensitivity to immune checkpoint blockade in advanced non-small cell lung cancer patients with EGFR exon 20 insertion mutations 34
INSL4 as prognostic marker for proliferation and invasiveness in non-small-cell lung cancer 31
Detection of egfr mutations in plasma cell-free tumor dna of tki-treated advanced-nsclc patients by three methodologies: Scorpion-arms, pnaclamp, and digital pcr 31
Prevalence and spectrum of brca germline variants in central Italian high risk or familial breast/ovarian cancer patients: A monocentric study 28
Clinical outcomes to pemetrexed-based versus non-pemetrexed-based platinum doublets in patients with KRAS-mutant advanced non-squamous non-small cell lung cancer 26
Antigen-Presenting Signaling Events in the Tumor Ecology Associate with Response to Anti-PD-1 Treatment in Lung Cancer 17
Lorlatinib beyond progression plus platinum/pemetrexed for ALK-positive non-small cell lung cancer patients: report of two cases 15
Assessment of TILs, IDO-1 and PD-L1 in resected non small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications. 14
RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion 11
RET Rearrangement as a Predictor of Unresponsiveness to Immunotherapy in Non-Small Cell Lung Cancer: Report of Two Cases with Review of the Literature 6
Totale 1.274
Categoria #
all - tutte 6.532
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.532


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202052 0 0 0 0 0 0 0 10 10 26 5 1
2020/202192 1 3 7 0 32 6 1 4 6 2 3 27
2021/2022181 1 25 3 6 3 2 0 63 24 14 16 24
2022/2023438 21 84 5 54 39 30 0 21 163 3 15 3
2023/2024175 12 8 16 5 5 1 40 2 7 4 38 37
2024/2025220 7 35 42 16 54 41 14 11 0 0 0 0
Totale 1.274